. Author manuscript; available in PMC: 2019 Jul 1.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 Oct 8;28(1):110–118. doi: 10.1158/1055-9965.EPI-18-0598

Table 4:

Relationship between CRP with lung cancer survival in the NLST¹

	N	HR (95% C.I.)	P^*	N	HR (95% C.I.)	P^{^}

*CRP*
<25^th Percentile	19	Reference		12	Reference
25^th – 50^th Percentile	40	0.65 (0.26–1.62)	0.35	32	0.87 (0.32–2.36)	0.78
50^th – 75^th Percentile	41	1.37 (0.60–3.12)	0.45	36	1.62 (0.64–4.09)	0.31
>75^th Percentile	34	2.28 (1.02–5.07)	0.04	33	2.77 (1.10–6.96)	0.03
Trend		1.52 (1.18–1.96)	0.001		1.57 (1.18–2.07)	0.002

P adjusted for age, gender, smoking status, race, pack-years of smoking, treatment status, tumor stage and tumor histology.

^{^}

P adjusted for age, gender, smoking status, race, pack-years of smoking, treatment status, tumor stage and tumor histology (with BAC removed).

denotes samples with a blood draw at the time of the screen/cancer diagnosis (n=134).